A review of concurrent chemoradiotherapy using cisplatin and oral vinorelbine in patients with non-small cell lung cancer (NCSLC) at the Kent Oncology Centre

被引：0
作者：
Baldry, C. [1 ]
Burcombe, R. [1 ]
Taylor, H. [1 ]
Cominos, M. [2 ]
Beesley, S. [1 ]
Visioli, A. [1 ]
Shah, R. [1 ]
Sevitt, T. [1 ]
机构：
[1] Kent Oncol Ctr, Maidstone, Kent, England
[2] Kent Oncol Ctr, Canterbury, Kent, England
来源：
LUNG CANCER | 2012年 / 75卷
关键词：
D O I：
10.1016/S0169-5002(12)70154-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
153
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
  • [21] Vinorelbine, ifosfamide and cisplatin in advanced non-small cell lung cancer
    Tan, EH
    Ang, PT
    Wee, J
    Fong, KW
    Leong, SS
    Khoo, KS
    [J]. ACTA ONCOLOGICA, 1999, 38 (05) : 619 - 622
  • [22] Vinorelbine and Cisplatin in Patients with Advanced Non-small Cell Lung Cancer with Interstitial Pneumonia
    Watanabe, Naohiro
    Niho, Seiji
    Kirita, Keisuke
    Umemura, Shigeki
    Matsumoto, Shingo
    Yoh, Kiyotaka
    Ohmatsu, Hironobu
    Goto, Koichi
    [J]. ANTICANCER RESEARCH, 2015, 35 (03) : 1697 - 1701
  • [23] Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer
    Horinouchi, Hidehito
    Sekine, Ikuo
    Sumi, Minako
    Noda, Kazumasa
    Goto, Koichi
    Mori, Kiyoshi
    Tamura, Tomohide
    [J]. CANCER SCIENCE, 2013, 104 (01) : 93 - 97
  • [24] Oral vinorelbine in combination with carboplatin for the treatment of inoperable non-small cell lung cancer (NSCLC) - the Kent Experience
    Raman, R.
    Burcombe, R. J.
    Beesley, S.
    Shah, R.
    Taylor, H.
    [J]. LUNG CANCER, 2007, 57 : S4 - S5
  • [25] Gefitinib (IRESSA) with vinorelbine or vinorelbine/cisplatin for chemotherapy-naive non-small cell lung cancer patients
    Pujol, Jean-Louis
    Viens, Patrick
    Rebattu, Paul
    Laurie, Scott A.
    Feld, Ronald
    Deneulin, Anne
    Fandi, Abderrahim
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (05) : 417 - 424
  • [26] Concurrent chemoradiotherapy for elderly patients with stage III non-small cell lung cancer
    Kang, Ki Mun
    Jeong, Bae Kwon
    Ha, In Bong
    Chai, Gyu Young
    Lee, Gyeong Won
    Kim, Hoon Gu
    Kang, Jung Hoon
    Lee, Won Seob
    Kang, Myoung Hee
    [J]. RADIATION ONCOLOGY JOURNAL, 2012, 30 (03): : 140 - 145
  • [27] Induction Chemotherapy with Vinorelbine/Cisplatin followed by Docetaxel with Concurrent Radiotherapy in Patients with Locally Advanced Non-Small Cell Lung Cancer
    Abdelwahab, Sherif
    Azmy, Ali
    Riad, Atef
    Abdulla, Hatem
    Abdel-Aziz, Hany
    Margerges, Maha
    Refae, Ahmed
    Dwedar, Ibrahim
    Sharma, Vinay
    Stojkovski, Igor
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2009, 32 (01): : 100 - 100
  • [28] Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review
    Lesueur, Paul
    Martel-Laffay, Isabelle
    Escande, Alexandre
    Kissel, Manon
    Locher, Chrystel
    Gervais, Radj
    Schott, Roland
    Vergnenegre, Alain
    Chouaid, Christos
    [J]. EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (11) : 1159 - 1165
  • [29] Concurrent chemoradiation with cisplatin and vinorelbine followed by consolidation with oral vinorelbine in locally advanced non-small cell lung cancer (NSCLC): the phase II CONCAVE study
    Hughes, Brett G. M.
    Ahern, Elizabeth
    Lehman, Margot
    Pratt, Gary
    Dauth, Margaret
    Pritchard, Wendy
    Wockner, Leesa
    Horwood, Keith
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (03) : 137 - 144
  • [30] Evaluation of oral vinorelbine for the management of non-small cell lung cancer
    Ward, C.
    [J]. LUNG CANCER, 2009, 63 : S9 - S9
12345